оценка соотношения "польза-риск"(What is benefit-risk evaluation? The review of the benefits and the risks associated with a medicinal product is called benefit–risk assessment. • Benefit-risk assessment is an integral part of FDA's regulatory review of marketing applications for new drugs and biologics. • The review of the benefits and the risks associated with a medicinal product is called benefit–risk assessment.)
процент пациентов с улучшением клинических показателей(Disease Control Rate (DCR) and Clinical Benefit Rate (CBR) are defined as the percentage of patients with advanced or metastatic cancer who have achieved complete response, partial response and stable disease to a therapeutic intervention in clinical trials of anticancer agents. amatsyuk)
